The global glycosylated peptide market is anticipated to grow at a considerable CAGR during the forecast period (2022-2028). The global market for the glycosylated peptide is growing due to the increasing prevalence of diabetes across the globe and the growing geriatric population along with unhealthy lifestyles will drive the market during the forecast period. Furthermore, significant growth in the biopharmaceutical industry and increasing R&D activities to develop more targeted glycosylated peptides further boost the growth of the market.
Browse the full report description “Global Glycosylated Peptide Market Size, Share and Trends Analysis Report, By Type (Monoclonal Antibodies (MABs), Erythropoietin (EPO), and Others), By Application (Oncology, Blood Disorder, and Others), Forecast (2022-2028)” at https://www.omrglobal.com/industry-reports/glycosylated-peptide-market
Moreover, increasing investment by the pharmaceutical companies to increase the utilization of the glycosylated peptide products and mergers with other companies will further drive the global glycosylated peptide market. For instance, in February 2022, Biocon Biologics Ltd. a subsidiary of Biocon ltd. announced that the company has entered into a definitive agreement with its partner Viatris Inc. to acquire Viatris’ biosimilars business to create a unique fully integrated global biosimilars enterprise. Viatris will receive consideration of up to $3.335 billion, including cash up to $2.335 billion and compulsorily convertible preference shares in Biocon Biologics Ltd. valued at $1 billion.
However, the major challenge faced by the global glycosylated peptide market is the complexities of manufacturing and the high cost of the active pharmaceutical ingredient (API), which in turn in will restrain the growth of the market. Furthermore, low economic conditions and a lack of favorable insurance systems may also hinder the growth of the global glycosylated peptide market. Moreover, some major players in the market include Bachem Group, Biocon Ltd., Celltrion Healthcare Co. Ltd., Dr. Reddy’s Laboratories Ltd., Teva Pharmaceutical Industries Ltd., among others.
Market Coverage
Segment Covered-
Regions Covered-
Competitive Landscape- Bachem Group, Biocon Ltd., Celltrion Healthcare Co. Ltd., Dr. Reddy’s Laboratories Ltd., Teva Pharmaceutical Industries Ltd., among others.
Key questions addressed by the report
o Deviation from the pre-COVID-19 forecast
o Most affected region and segment
Global Glycosylated Peptide Market Report Segment
By Type
By Application
Global Glycosylated Peptide Market Report Segment by Region
North America
Europe
Asia-Pacific
Rest of the World
To learn more about this report request a free sample copy @ https://www.omrglobal.com/request-sample/glycosylated-peptide-market